Isiklar I, Leeds N E, Fuller G N, Kumar A J
Department of Diagnostic Imaging, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
AJR Am J Roentgenol. 1995 Dec;165(6):1503-12. doi: 10.2214/ajr.165.6.7484597.
Preliminary reports based on limited numbers of cases have proposed that specific MR imaging patterns may permit a distinction between melanotic and amelanotic brain metastases in melanoma patients. The purpose of this study was to test this hypothesis by categorizing MR images obtained from a large series of patients and correlating the results with the percentage of melanin-containing cells in surgically resected metastases.
The MR images of 30 patients with histologically proven intracerebral melanoma were reviewed retrospectively. Precontrast MR images were obtained with T1-weighted spin-echo sequences in axial and sagittal sections and with proton density-weighted and T2-weighted sequences in axial sections. After IV injection of gadopentetate dimeglumine (0.1 mmol/kg of body weight), T1-weighted images were obtained in axial and coronal sections. All patients had undergone gross total resection of the evaluated lesions. MR images of the metastases were reviewed and sorted into four groups on the basis of putative patterns: (1) melanotic pattern--hyperintense in relation to cortex on T1-weighted images, hypointense in relation to cortex on T2-weighted images, and isointense or hyperintense in relation to cortex on proton density-weighted images; (2) amelanotic pattern--hypointense or isointense in relation to cortex on T1-weighted images and hyperintense or isointense in relation to cortex on T2-weighted and proton density-weighted images; (3) indeterminate, or mixed, pattern--MR imaging characteristics that did not conform to those of one of the first two categories; and (4) hematoma pattern--MR imaging features that exhibited only hematoma characteristics. Tissue sections from all evaluated lesions were independently reviewed by a neuropathologist (G.N.F.), and the percentage of melanin-containing tumor cells in each resected metastatic lesion was estimated. The MR imaging data and histologic data were then compared to assess the predictive value of the MR imaging patterns.
Forty-two metastatic lesions were identified and categorized by MR imaging pattern as follows: 10 melanotic, 11 indeterminate (mixed), 16 amelanotic, and five hematoma. Correlation with histologic findings revealed that a majority (7/10) of lesions that exhibited a melanotic MR imaging pattern had more than 10% melanin-containing cells, over half (9/16) of lesions that exhibited an amelanotic MR imaging pattern contained histologically identifiable melanin (but always in less than 10% of cells), and lesions that exhibited a mixed MR imaging pattern were either amelanotic or contained less than 10% melanotic cells. Conversely, a majority of lesions containing more than 10% melanotic cells (7/8) demonstrated the typical melanotic MR imaging pattern, lesions with less than 10% melanin-containing cells exhibited a variety of MR imaging patterns, and only about half of patients with amelanotic lesions (6/13) showed the characteristic amelanotic MR imaging pattern. For five lesions, potentially informative imaging data on melanin content was obscured by histologically documented hematoma formation.
Only a minority of melanoma metastases have the anticipated MR imaging findings of melanotic melanoma, which consist of high signal intensity relative to that of cortex on T1-weighted images and low signal intensity relative to that of cortex on T2-weighted images. Of tumors that do exhibit this melanotic pattern, the majority have more than 10% melanin-containing cells. The putative MR imaging pattern for amelanotic melanoma is nonspecific, as over half of tumors with this pattern contain melanin.
基于有限病例数的初步报告提出,特定的磁共振成像(MR)模式可能有助于区分黑色素瘤患者的黑色素性和无黑色素性脑转移瘤。本研究的目的是通过对大量患者的MR图像进行分类,并将结果与手术切除转移瘤中含黑色素细胞的百分比进行关联,来验证这一假设。
回顾性分析30例经组织学证实的脑内黑色素瘤患者的MR图像。采用T1加权自旋回波序列在轴位和矢状位获取平扫MR图像,采用质子密度加权和T2加权序列在轴位获取图像。静脉注射钆喷酸葡胺(0.1 mmol/kg体重)后,在轴位和冠状位获取T1加权图像。所有患者均接受了所评估病灶的全切除。根据假定模式对转移瘤的MR图像进行回顾并分为四组:(1)黑色素性模式——在T1加权图像上相对于皮质呈高信号,在T2加权图像上相对于皮质呈低信号,在质子密度加权图像上相对于皮质呈等信号或高信号;(2)无黑色素性模式——在T1加权图像上相对于皮质呈低信号或等信号,在T2加权和质子密度加权图像上相对于皮质呈高信号或等信号;(3)不确定或混合模式——MR成像特征不符合前两类中的任何一类;(4)血肿模式——仅表现出血肿特征的MR成像表现。由神经病理学家(G.N.F.)独立复查所有评估病灶的组织切片,并估计每个切除转移瘤中含黑色素肿瘤细胞的百分比。然后比较MR成像数据和组织学数据,以评估MR成像模式的预测价值。
共识别出42个转移瘤病灶,并根据MR成像模式分类如下:10个黑色素性、11个不确定(混合)、16个无黑色素性和5个血肿。与组织学结果的相关性显示,表现出黑色素性MR成像模式的病灶中,大多数(7/10)含黑色素细胞超过10%;表现出无黑色素性MR成像模式的病灶中,超过半数(9/16)在组织学上可识别黑色素(但始终少于细胞的10%);表现出混合MR成像模式的病灶要么是无黑色素性的,要么含黑色素细胞少于10%。相反,含黑色素细胞超过10%的病灶中,大多数(7/8)表现出典型的黑色素性MR成像模式;含黑色素细胞少于10%的病灶表现出多种MR成像模式;无黑色素性病灶的患者中,只有约半数(6/13)表现出特征性的无黑色素性MR成像模式。5个病灶的黑色素含量的潜在有用成像数据因组织学证实的血肿形成而模糊不清。
只有少数黑色素瘤转移瘤具有预期的黑色素性黑色素瘤的MR成像表现,即T1加权图像上相对于皮质呈高信号强度,T2加权图像上相对于皮质呈低信号强度。在确实表现出这种黑色素性模式的肿瘤中,大多数含黑色素细胞超过10%。无黑色素性黑色素瘤的假定MR成像模式不具有特异性,因为具有这种模式的肿瘤中超过半数含有黑色素。